Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Botulinum toxin screening assays

Botulinum toxin screening assays

US Patent 7598027 · Granted Oct 6, 2009

Estimated economic value: $48,331,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyrimidines as EED inhibitors and the use thereof2024
Anti-CD39 antibodies and use thereof2024
Fused 1,4-oxazepines as BET protein degraders2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
BET bromodomain protein degraders with cleavable linkers2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based retargeted endopeptidase activity assays2021
Immuno-based botulinum toxin serotype A activity assays2020